21. ミトコンドリア病 Mitochondrial disease Clinical trials / Disease details


臨床試験数 : 39 薬物数 : 42 - (DrugBank : 32) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 67

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2021-001268-58-HU
(EUCTR)
06/07/202121/03/2021Investigation of effects of cariprazine in patients with mitochondrial schizophreniaInvestigation of cellbiological effects of cariprazine in patients with mitochondrial schizophrenia Mitochondrial disease associated schizophrenia
MedDRA version: 20.0;Level: PT;Classification code 10039626;Term: Schizophrenia;System Organ Class: 10037175 - Psychiatric disorders;Therapeutic area: Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04]
Trade Name: Reagila
Product Name: Reagila
Semmelweis University, STIA-POC-2020NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
10Phase 4Hungary